BioinvestGPT Proposes Patient-Data-Free AI Tool Class for FDA Early-Phase Clinical Trial Pilot Program
2026-06-10
PubComNonGov2026-06-10
Carter Struck
WASHINGTON, June 10 -- BioinvestGPT ApS, a Copenhagen, Denmark-based company, submitted a public comment letter to the Food and Drug Administration outlining a proposal for an artificial intelligence . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, June 10 -- BioinvestGPT ApS, a Copenhagen, Denmark-based company, submitted a public comment letter to the Food and Drug Administration outlining a proposal for an artificial intelligence . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026